VEGF signaling: Role in angiogenesis and beyond

P Shaw, SKD Dwivedi, R Bhattacharya… - … et Biophysica Acta (BBA …, 2024 - Elsevier
Angiogenesis is a crucial process for tissue development, repair, and tumor survival.
Vascular endothelial growth factor (VEGF) is a key driver secreted by cancer cells …

Veliparib (ABT-888), a PARP inhibitor potentiates the cytotoxic activity of 5-fluorouracil by inhibiting MMR pathway through deregulation of MSH6 in colorectal cancer …

S Paul, S Chatterjee, S Sinha, SR Dash… - Expert Opinion on …, 2023 - Taylor & Francis
Objective Sensitization of mismatch repair (MMR)-deficient colorectal cancer (CRC) cells by
5-Fluorouracil (5-FU) is well-documented. But not much is known about the treatment of …

Cancer stem cells and the tumor microenvironment in tumor drug resistance

Q Gao, Y Zhan, L Sun, W Zhu - Stem Cell Reviews and Reports, 2023 - Springer
Although there has been some progress in the efficacy of anti-cancer drugs, drug resistance
remains challenging. Cancer stem cells (CSCs) are self-renewing and differentiate into …

Hypoxia inducible factor-1α (HIF-1α) in breast cancer: The crosstalk with oncogenic and onco-suppressor factors in regulation of cancer hallmarks

S Mirzaei, B Ranjbar, SH Tackallou, AR Aref - Pathology-Research and …, 2023 - Elsevier
Low oxygen level at tumor microenvironment leads to a condition, known as hypoxia that is
implicated in cancer progression. Upon hypoxia, HIF-1α undergoes activation and due to its …

Nano formulated Resveratrol inhibits PD-L1 in oral cancer cells by deregulating the association between tumor associated macrophages and cancer associated …

R Pradhan, S Paul, SS Acharya, S Sinha… - The Journal of …, 2024 - Elsevier
Tumor associated macrophages (TAMs) and cancer-associated fibroblasts (CAFs) in the
tumor microenvironment secrete several cytokines, which involved in tumor initiation …

Recent developments in targeting breast cancer stem cells (BCSCs): a descriptive review of therapeutic strategies and emerging therapies

K Ali, M Nabeel, F Mohsin, M Iqtedar, M Islam… - Medical Oncology, 2024 - Springer
Despite recent advancements in the diagnosis and treatment of breast cancer (BC), patient
outcomes in terms of survival, recurrence, and disease progression remain suboptimal. A …

α-Amylase and mycobacterium-TB H37Rv antagonistic efficacy of novel pyrazole-coumarin hybrids: an in vitro and in silico investigation

DC Kanjariya, HN Naik, MJ Sherashiya… - Journal of …, 2024 - Taylor & Francis
The present investigation of minutiae to acquire structural information of the novel pyrazole-
coumarin hybrids (PC1-PC10) synthesized using ultrasound methods and characterized …

Synergistic Therapy of Metastatic Breast Cancers by Biomimetic Chemotherapeutic Drug-Gene Nanoparticles

J Ren, Y Han, J Xu, T Chen, W Huang… - ACS Applied Materials & …, 2024 - ACS Publications
Cancer metastasis is responsible for more than 90% of tumor-related deaths. Especially,
metastatic breast cancer (MBC) is a common malignancy with a high mortality among …

c-Met pathway in human malignancies and its targeting by natural compounds for cancer therapy

CD Mohan, MK Shanmugam, SGS Gowda… - Phytomedicine, 2024 - Elsevier
Background c-MET is a receptor tyrosine kinase which is classically activated by HGF to
activate its downstream signaling cascades such as MAPK, PI3K/Akt/mTOR, and STAT3 …

AI identifies potent inducers of breast cancer stem cell differentiation based on adversarial learning from gene expression data

Z Li, A Napolitano, M Fedele, X Gao… - Briefings in …, 2024 - academic.oup.com
Cancer stem cells (CSCs) are a subpopulation of cancer cells within tumors that exhibit stem-
like properties and represent a potentially effective therapeutic target toward long-term …